Fluid infusion during labor to prevent heavy bleeding after birth
Part of Women’s health & pregnancy clinical trials.
This study tests whether putting extra sterile fluid into the womb during labor helps prevent severe bleeding after giving birth. If you're at medium or high risk for postpartum hemorrhage, this simple procedure might make delivery safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are carrying one baby (not twins, triplets, etc.)
- You are at least 34 weeks pregnant (about 8 months)
- Labor has started on its own or is being medically induced
- You are considered at medium or high risk for heavy bleeding after birth, based on your doctor's assessment
- You are not planning to have a scheduled C-section (vaginal delivery is expected)
- You do not have an active HIV infection (because a special internal monitor is used in this study)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special balloon placed in the womb can stop heavy bleeding after childbirth when standard medicines don't work. This could help avoid more serious surgery and keep you safe.
This trial tests if draining blood from the umbilical cord after delivery can help prevent postpartum hemorrhage (heavy bleeding) in women having a vaginal birth. It may offer a simple way to reduce risk.
This trial tests two emergency treatments to control heavy bleeding after childbirth when standard medicines haven't worked. One uses a small balloon placed inside the womb, and the other uses a special gauze that helps blood clot.
This trial tests if draining blood from the umbilical cord after birth can reduce bleeding during the third stage of labor. It might help make delivery safer and lower the risk of hemorrhage.
This trial tests two medicines given during a planned C-section to see which is better at preventing heavy bleeding. It may help make delivery safer for healthy women having a scheduled cesarean.
This trial tests whether a continuous oxytocin infusion during a C-section helps maintain labor progress in people already receiving oxytocin. It may help reduce labor-related complications, but only if you meet the safety requirements for anesthesia and pregnancy conditions.
Hear when a new Postpartum Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.